http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014052849-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5fcd696800ab45b4d9cb014dd9ecff6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80506d614f82cb45a6f32ee0925649b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c98b407bba7cb229d1dc0d768468b2ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01d7935508cbe002beb151d4efde669
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2ecb0cf72c2e375620f8e30317532b3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
filingDate 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394bebcc1f7fc216774e30524dbce8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba0317f66bd9ecf8e0eb9d7a2f982cf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c2f3f56dda5ff3b1c8e14f4b763e9a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb76171bccac8bd75577f8d763dd9f4a
publicationDate 2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014052849-A1
titleOfInvention Combination treatments for bipolar disorders
abstract The invention relates generally to novel compositions and methods comprising a scyllo-inositol compound and one or both of valproic acid compound and lamotrigine. The compositions and methods provide beneficial effects in the treatment of bipolar disorders.
priorityDate 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008106659-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007060550-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129178651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128706830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127697018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127607286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127607283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129937529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128442098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12281060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129491650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127976059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129583405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124028529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID328022834

Total number of triples: 57.